AzTrials
AzTrials

Mental Health DisordersiCASNCT02023957

A Pilot With Interactive Computer-assisted Screening for Mental Health in Primary Care

A study testing Interactive computer-assisted screening (iCAS) in people with Mental Health Disorders, run by York University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current protocol pertains to the evaluation of the interactive computer-assisted screening (iCAS) tool through a pilot randomized control trial. The purpose of this evaluation is to determine the efficacy of the iCAS tool in improving clinician's detection of common mental health conditions (i.e. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Mental Health Disorders
What is being tested?
Interactive computer-assisted screening (iCAS)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
154 participants
Where
1 siteCanada
Study dates
Nov 2013to May 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • At least 18 years of age
  • Speak/read Spanish
  • Speak/read English
  • Visiting the consenting clinician

Who cannot join

  • Patient accompanied by a family member for interpretation
  • New patients coming for first visit
  • Patients feeling unwell (self-report)
  • Inability of the research staff to offer study details in privacy

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • York University

    Toronto, Ontario, M3J 1P3

Other trials in Canada

About this study

Official title: Interactive Computer-assisted Screening for Mental Health in Primary Care

The current protocol pertains to the evaluation of the interactive computer-assisted screening (iCAS) tool through a pilot randomized control trial. The purpose of this evaluation is to determine the efficacy of the iCAS tool in improving clinician's detection of common mental health conditions (i.e. major depression/generalized anxiety/post-traumatic stress disorder/alcohol dependence), and patients' discussion on mental health.

Read the detailed description

The iCAS tool is a health-risk assessment survey that is completed by adult patients using touch-screen iPad device in their waiting time before seeing their clinician (family physician or nurse practitioner). The computer program generates tailored risk-report for the clinician and a simple recommendation sheet for the patient, with community resources and health information, at the point of care. The iCAS tool currently includes validated screening scales for depression, generalized anxiety, posttraumatic stress disorder and alcohol abuse. There are some questions on the social determinants of mental health as well. The current versions of the tool are in English and Spanish; a Chinese language version will also be developed.

Being tested
Interactive computer-assisted screening (iCAS)
Keywords
Interactive Health-risk assessment, Primary Care, Randomized, Open Label, Efficacy Study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interactive computer-assisted screening (iCAS)Behavioural

Study groups in NCT02023957
Study groupRoleWhat they receive
Interactive computer-assisted screeningExperimentalEligible patients completed the interactive computer-assisted screening (iCAS) tool in English or Spanish before seeing the consenting clinician. Participating patients then received the iCAS generated tailored recommendation sheet. Participating clinicians received the iCAS generated risk report.
Receives: Behavioral: Interactive computer-assisted screening (iCAS)
Usual CareNo interventionEligible patients randomized to the control group completed their standard visit to the participating clinician. There was no pre-visit health risk screening. There were no tailored reports for the patients or clinicians.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinician Detection (probable, sub-clinical, confirmed) of major depression or generalized anxiety or post-traumatic stress disorder or alcohol dependence

    Chart review for the index visit

    Measured: Day 1

  2. Patient discussion on mental health

    Exit Survey of patients after the index visit

    Measured: Day 1

Secondary outcomes (4)
  1. Patient intention to see a mental health counselor

    Exit Survey of patients after the index visit

    Measured: Day 1

  2. Patient satisfaction with health services

    Exit Survey of patients after the index visit

    Measured: Day 1

  3. Patient enablement to cope with these conditions

    Exit Survey of patients after the index visit

    Measured: Day 1

  4. Patient adherence to follow-up advice and referrals to mental health support

    Chart review

    Measured: 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2013 (estimated)
  2. Study startNov 2013
  3. Primary completionMay 2014
  4. Study completionMay 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
154 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02023957
Sponsor's protocol ID
e2013 - 291
Acronym
iCAS
Status last verified
Jun 2016
First submitted
12 Dec 2013
Last updated
3 Jun 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Ahmad F, Lou W, Shakya Y, Ginsburg L, Ng PT, Rashid M, Dinca-Panaitescu S, Ledwos C, McKenzie K. Preconsult interactive computer-assisted client assessment survey for common mental disorders in a community health centre: a randomized controlled trial. CMAJ Open. 2017 Mar 1;5(1):E190-E197. doi: 10.9778/cmajo.20160118. eCollection 2017 Jan-Mar.

    PubMed 28401134
  • Ferrari M, Ahmad F, Shakya Y, Ledwos C, McKenzie K. Computer-assisted client assessment survey for mental health: patient and health provider perspectives. BMC Health Serv Res. 2016 Sep 23;16(1):516. doi: 10.1186/s12913-016-1756-0.

    PubMed 27663508

Questions about this trial

What is this clinical trial studying?

A study testing Interactive computer-assisted screening (iCAS) in people with Mental Health Disorders, run by York University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinician Detection (probable, sub-clinical, confirmed) of major depression or generalized anxiety or post-traumatic stress disorder or alcohol dependence (time frame: Day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02023957, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in